GENE ONLINE|News &
Opinion
Blog

Immunotherapy
FDA Drops New Oncology Development Guidelines
2022-10-18
CHMP Gives Kite’s Lymphoma Immunotherapy a Positive Opinion
2022-09-16
Dren Bio Draws $65 Million, Aiming for Phase 1 of ADCC Lead
2022-06-15
Europe Okays Roche’s CAR-T Competitor for Blood Cancer
2022-06-09
DNA
Antitumor Response of Left-handed Z-DNA Reinvigorates Immunotherapy’s Efficacy
2022-06-02
Novartis CAR-T Cell Therapy Receives FDA Approval for Third Indication to Treat Follicular Lymphoma
2022-05-30
Stanford Touts Remote-Controllable CAR-T Cell Therapy
2022-05-26
These Companies Are Harnessing Oncolytic Viruses to Target Cancer
2022-05-25
EU Expands Merck’s Keytruda Use on Breast Cancer
2022-05-25
AbbVie’s Big Moves; Expanding with One Company, Cutting Ties with Another
2022-04-21
Kite’s Yescarta – The First CAR-T Cell Therapy Approved for B cell Lymphoma
2022-04-06
Roche’s Phase III Trial of ES-SCLC Immunotherapy Fails to Extend Progression-Free Survival
2022-04-05
Pfizer: Pneumonia Shot Can Be Given with COVID-19 Vaccine in Older Adults
2022-01-16
Recent Advances in Breast Cancer Treatments: An Overview
2022-01-15
Novartis Licenses BeiGene’s Antibody for a Potential $2.8 Billion After Its Own Drug Disappoints
2021-12-21
1 2 3 4 8
LATEST
Early Patient Involvement in Drug Development Linked to Reduced Costs and Faster Timelines
2026-04-15
One in Four U.S. Adults Turns to AI Tools for Health Care Advice
2026-04-15
Policy, Pricing, and Power: Why Europe’s Biotech Future Depends on Openness, Not Overregulation
2026-04-14
Vitiligo: Causes, Life-Changing Impacts, Treatment Challenges, and Breakthrough New Drugs
2026-04-14
Chris Chen Presents Faraday Future AI Robotics Advancements at Harvard Science Center
2026-04-14
General Lance W. Lord to Receive Space Foundation Lifetime Space Achievement Award for Leadership in Military Space Operations
2026-04-14
Ronald Kopas Reports 11.2 Percent Ownership in Delta Resources Following Private Share Acquisition
2026-04-14
Scroll to Top